These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1906557)

  • 1. [Isolation of urinary heparan sulfate and chondroitin sulfate and their inhibitory activity of calcium oxalate crystal growth].
    Iwata H; Terado T; Kin M; Nishio S; Matsumoto A; Takeuchi M
    Nihon Hinyokika Gakkai Zasshi; 1991 Mar; 82(3):405-11. PubMed ID: 1906557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separate effects of urinary chondroitin sulphate and heparan sulphate on the crystallization of urinary calcium oxalate: differences between stone formers and normal control subjects.
    Shum DK; Gohel MD
    Clin Sci (Lond); 1993 Jul; 85(1):33-9. PubMed ID: 8149691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibitory factors of calcium oxalate crystal growth in urinary macromolecules].
    Matsumoto A; Terado T; Kin M; Nishio S; Iwata H; Takeuchi M
    Nihon Hinyokika Gakkai Zasshi; 1990 Jun; 81(6):883-8. PubMed ID: 2402111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis.
    Gohel MD; Shum DK; Tam PC
    Carbohydr Res; 2007 Jan; 342(1):79-86. PubMed ID: 17145044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive diagnosis of tubular damage by the use of the urinary chondroitin-4-sulfate/heparan sulfate ratio.
    Lubec G; Kircher S; Grillenberger A
    Padiatr Padol; 1986; 21(4):357-61. PubMed ID: 2951642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of glycosaminoglycans on calcium oxalate crystal formation].
    Shirane Y; Hamao T; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1990 Jul; 81(7):1065-70. PubMed ID: 2214470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary glycosaminoglycans and glycoproteins in a calcium oxalate crystallization system.
    Poon NW; Gohel MD
    Carbohydr Res; 2012 Jan; 347(1):64-8. PubMed ID: 22119438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glycosaminoglycans on calcium oxalate crystal aggregation.
    Shirane Y; Yamamoto A; Mizuta K; Kagawa S
    Tokushima J Exp Med; 1989 Dec; 36(3-4):81-5. PubMed ID: 2517714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperation of binding sites at the hydrophilic domain of cell-surface sulfatase Sulf1 allows for dynamic interaction of the enzyme with its substrate heparan sulfate.
    Milz F; Harder A; Neuhaus P; Breitkreuz-Korff O; Walhorn V; Lübke T; Anselmetti D; Dierks T
    Biochim Biophys Acta; 2013 Nov; 1830(11):5287-98. PubMed ID: 23891937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low sulfated glycosaminoglycans are excreted in patients with the Lowe syndrome.
    Kieras FJ; Houck GE; French JH; Wisniewski K
    Biochem Med; 1984 Apr; 31(2):201-10. PubMed ID: 6426474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation, identification, and quantitation of urinary glycosaminoglycans.
    Lee EY; Kim SH; Whang SK; Hwang KY; Yang JO; Hong SY
    Am J Nephrol; 2003; 23(3):152-7. PubMed ID: 12646785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
    Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
    Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
    Zhang H; Wood T; Young SP; Millington DS
    Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin sulfate in the stone matrix and its inhibitory effect on calcium oxalate crystallization.
    Yamaguchi S; Yoshioka T; Utsunomiya M; Koide T; Osafune M; Okuyama A; Sonoda T
    Urol Res; 1993 May; 21(3):187-92. PubMed ID: 8342253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural properties of the heparan sulfate proteoglycans of brain.
    Ripellino JA; Margolis RU
    J Neurochem; 1989 Mar; 52(3):807-12. PubMed ID: 2521892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary acid glycosaminoglycans in a patient with oculo-cerebro-renal syndrome.
    Hayashi S; Nagata T; Kimura A; Tsurumi K
    Tohoku J Exp Med; 1978 Nov; 126(3):225-34. PubMed ID: 734647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive diagnosis of tubular damage by the use of urinary chondroitin-4-sulfate/heparan sulfate ratio.
    Lubec G; Kircher S
    Nephron; 1986; 42(4):340. PubMed ID: 2938022
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemostatic properties and serum lipoprotein binding of a heparan sulfate proteoglycan from bovine aorta.
    Vijayagopal P; Srinivasan SR; Radhakrishnamurthy B; Berenson GS
    Biochim Biophys Acta; 1983 Jul; 758(1):70-83. PubMed ID: 6222769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cetylpyridinium chloride and cetyltrimethylammonium bromide extractive procedures for quantification and characterization of human urinary glycosaminoglycans.
    Buzzega D; Pederzoli F; Maccari F; Aslan D; Türk M; Volpi N
    Clin Chem Lab Med; 2010 Aug; 48(8):1133-9. PubMed ID: 20441479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.